It is a pharma private limited company based in Jamshedpur, Jharkhand, India, established in 2018.
2018 | Jamshedpur, Jharkhand, India | ActiveRedosine Pharmaceutical Private Limited, a active private limited company, was established on 15 June 2018 in Jamshedpur, Jharkhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999JH2018PTC011520. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Hemant Kumar Das (Director), Ranjeet Kumar Singh (Director). Past directors included Pankaj Kumar. It holds ₹1.31 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sai Niwas Complex Flat No. B1/206, Baliguma, Mango, Jamshedpur, Jharkhand, 831018.
U74999JH2018PTC011520
011520
15 June 2018
₹0.50 M
₹0.10 M
Roc Ranchi
Unlisted
Active
Explore comprehensive insights into Redosine Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemant Kumar Das | Director | 15 Jun 2018 | Current |
| Ranjeet Kumar Singh | Director | 15 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Redosine Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 149.82% increase. The company also saw a substantial improvement in profitability, with a 127.35% increase in profit. The company's net worth Soared by an impressive increase of 88.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Redosine Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,310,665.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2025 | Hdfc Bank Limited | ₹0.59 M | Open |
| 23 Feb 2023 | Hdfc Bank Limited | ₹0.72 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Redosine Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Redosine Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redosine Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Redosine Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.59 M with Charge ID 101149884 was registered on 10 Jun 2025. was recorded as a recent event.
The activity Redosine Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.72 M with Charge ID 100730323 was registered on 23 Feb 2023. was documented.
Hemant Kumar Das was appointed as a Director was appointed as a Director on 15 Jun 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
The activity Ranjeet Kumar Singh was appointed as a Director was appointed as a Director on 15 Jun 2018 & has been associated with this company since 7 years 6 months . was completed.
The CIN of Redosine Pharmaceutical Private Limited is U74999JH2018PTC011520.
Redosine Pharmaceutical Private Limited is headquartered at Sai Niwas Complex Flat No. B1/206, Baliguma, Mango, Jamshedpur, Jharkhand, 831018.
Redosine Pharmaceutical Private Limited was incorporated on 15 June 2018.
The current directors of Redosine Pharmaceutical Private Limited are
The primary industry of Redosine Pharmaceutical Private Limited is Manufacturing.
Redosine Pharmaceutical Private Limited is unlisted.
The authorized capital of Redosine Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX